Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model
Jeng‐Wei Lu, Yu Hsia, Wan-Yu Yang, et al.
Carcinogenesis (2011) Vol. 33, Iss. 1, pp. 209-219
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice
Jessica A. Bonzo, Christina H. Ferry, Tsutomu Matsubara, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 10, pp. 7345-7356
Open Access | Times Cited: 188
Role of Hepatocyte Nuclear Factor 4α (HNF4α) in Cell Proliferation and Cancer
Chad Walesky, Udayan Apte
Gene Expression (2015) Vol. 16, Iss. 3, pp. 101-108
Open Access | Times Cited: 134
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
Maria Rita Emma, Juan Iovanna, Dimcho Bachvarov, et al.
Cell Death and Disease (2016) Vol. 7, Iss. 6, pp. e2269-e2269
Open Access | Times Cited: 108
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
Harry Ho Man Ng, Ren Yuan Lee, Siting Goh, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000987-e000987
Open Access | Times Cited: 98
BMP signaling and its paradoxical effects in tumorigenesis and dissemination
Lijie Zhang, Yingnan Ye, Xin-Xin Long, et al.
Oncotarget (2016) Vol. 7, Iss. 47, pp. 78206-78218
Open Access | Times Cited: 88
Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
Ze‐Guang Han
Annual Review of Genomics and Human Genetics (2012) Vol. 13, Iss. 1, pp. 171-205
Closed Access | Times Cited: 96
HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway
Mingyue Zhu, Wei Li, Yan Lu, et al.
International Journal of Cancer (2016) Vol. 140, Iss. 6, pp. 1346-1355
Open Access | Times Cited: 82
BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma Cells
Blanca Herrera, María García‐Álvaro, Silvia Cruz-Gil, et al.
PLoS ONE (2013) Vol. 8, Iss. 7, pp. e69535-e69535
Open Access | Times Cited: 76
Bone morphogenetic protein‐9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cells
Qi Li, Xing Gu, Honglei Weng, et al.
Cancer Science (2013) Vol. 104, Iss. 3, pp. 398-408
Open Access | Times Cited: 72
Overexpression of Endothelin 1 Triggers Hepatocarcinogenesis in Zebrafish and Promotes Cell Proliferation and Migration through the AKT Pathway
Jeng‐Wei Lu, Chung-Yi Liao, Wan‐Yu Yang, et al.
PLoS ONE (2014) Vol. 9, Iss. 1, pp. e85318-e85318
Open Access | Times Cited: 71
BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma
Junli Ma, Shan Zeng, Yan Zhang, et al.
Cancer Letters (2017) Vol. 411, pp. 117-129
Closed Access | Times Cited: 67
Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform
Han-Syuan Lin, Yi-Luen Huang, Yi-Rui Stefanie Wang, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 739-739
Open Access | Times Cited: 54
BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
Blanca Herrera, Annalisa Addante, Aránzazu Sánchez
International Journal of Molecular Sciences (2017) Vol. 19, Iss. 1, pp. 39-39
Open Access | Times Cited: 61
Liver-Specific Expressions of HBx and src in the p53 Mutant Trigger Hepatocarcinogenesis in Zebrafish
Jeng‐Wei Lu, Wan‐Yu Yang, Su-Mei Tsai, et al.
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e76951-e76951
Open Access | Times Cited: 59
HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque
BioMed Research International (2013) Vol. 2013, pp. 1-14
Open Access | Times Cited: 57
Zebrafish as a disease model for studying human hepatocellular carcinoma
Jeng‐Wei Lu, Yi‐Jung Ho, Yi‐Ju Yang, et al.
World Journal of Gastroenterology (2015) Vol. 21, Iss. 42, pp. 12042-12042
Open Access | Times Cited: 57
There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma
Paul J. Wrighton, Isaac M. Oderberg, Wolfram Goessling
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 8, Iss. 3, pp. 347-363
Open Access | Times Cited: 43
Ribose‐5‐phosphate isomerase A regulates hepatocarcinogenesis viaPP2A and ERK signaling
Shih‐Ci Ciou, Yu‐Ting Chou, Yu‐Ling Liu, et al.
International Journal of Cancer (2014) Vol. 137, Iss. 1, pp. 104-115
Open Access | Times Cited: 46
The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Xiaobing Wu, Shuling Li, Xuehu Xu, et al.
PubMed (2015) Vol. 8, Iss. 3, pp. 2840-51
Closed Access | Times Cited: 41
The HBx–CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1
Yajun Li, Yongming Fu, Xingwang Hu, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 6
Open Access | Times Cited: 38
Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish
Jeng‐Wei Lu, Wan‐Yu Yang, Yueh‐Min Lin, et al.
Acta Histochemica (2013) Vol. 115, Iss. 7, pp. 728-739
Closed Access | Times Cited: 42
Evolving roles of circadian rhythms in liver homeostasis and pathology
Dexi Zhou, Yaqin Wang, Lu Chen, et al.
Oncotarget (2016) Vol. 7, Iss. 8, pp. 8625-8639
Open Access | Times Cited: 36
BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/CDKN1B signaling
Junli Ma, Shan Zeng, Yan Zhang, et al.
Molecular Carcinogenesis (2017) Vol. 56, Iss. 10, pp. 2279-2289
Closed Access | Times Cited: 35
<p>Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine</p>
Jingxian Duan, Yuling Wu, Jikui Liu, et al.
Journal of Hepatocellular Carcinoma (2019) Vol. Volume 6, pp. 151-166
Open Access | Times Cited: 31
Clinical Significance of Occult Hepatitis B Infection in Progression of Liver Disease and Carcinogenesis
Hiroki Nishikawa, Yukio Osaki
Journal of Cancer (2013) Vol. 4, Iss. 6, pp. 473-480
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top